| EMED Mining Public Limited: Update Regarding EGM Requisition Notice | |
| | |
|
NICOSIA, CYPRUS--(Marketwired - Dec 22, 2014) - EMED Mining Public Limited (TSX: EMD) (AIM: EMED)
TSX: EMD
22 December 2014
EMED Mining Public Limited
("EMED" or the "Company")
Update Regarding EGM Requisition Notice
EMED Mining Public Limited, the Europe-based minerals development and exploration company, provides the following update in relation to its discussions with Urion Holdings (Malta) Limited, a subsidiary of Trafigura Beheer B.V., who currently holds 19.35% of the issued share capital of the Company (the "Proposing Shareholder"). As announced on 17 November 2014, the Company and the Proposing Shareholder agreed to extend the time period for calling the extraordinary general meeting ("EGM") set out in the Proposing Shareholder's requisition notice to 20 December 2014.
The Company wishes to confirm that discussions with the Proposing Shareholder and other key stakeholders regarding the EGM and further funding remain ongoing and further updates will be made as appropriate.
Enquiries
EMED Mining |
|
Ronnie Beevor/ Alberto Lavandeira Adan |
|
+34 959 59 28 50 |
Canaccord Genuity |
|
Neil Elliot/Mark Palmer |
|
+44 207 523 8000 |
Fox-Davies Capital |
|
Oliver Stansfield |
|
+44 203 463 5061 |
Walbrook PR |
|
Nick Rome |
|
+44 207 933 8783 |
For further information on the Company's activities, visit www.emed-mining.com.
|
|
|
EMED Mining Public Ltd
|
|
DEVELOPMENT STAGE |
CODE : EMED.L |
ISIN : CY0000100319 |
|
| |
ProfileMarket IndicatorsVALUE : Projects & res.Press releasesAnnual reportRISK : Asset profileContact Cpy |
EMED is a gold and copper development stage company based in Cyprus. EMED develops gold, copper and zinc in Cyprus and in Spain, and holds various exploration projects in Cyprus. Its main assets in development are PROYECTO RIO TINTO in Spain and KLIROU in Cyprus and its main exploration properties are DETVA, STIAVNICA-HODRUSA and BIELY VRCH in Slovakia and KLIROU in Cyprus. EMED is listed in United Kingdom. Its market capitalisation is GBX 54.7 billions as of today (US$ 65.5 billions, € 57.4 billions). Its stock quote reached its lowest recent point on September 18, 2015 at GBX 0.12, and its highest recent level on January 17, 2022 at GBX 404.00. EMED has 135 475 650 shares outstanding. |